Kaposi Sarcoma

Published on 20/07/2015 by admin

Filed under Radiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2208 times

 Multifocal hypodense nodules or masses on CECT with delayed enhancement

• Gastrointestinal

image 50% of patients with cutaneous Kaposi sarcoma (KS) will have GI tract involvement
image Upper GI tract (especially stomach and duodenum) most common, but can affect any part of GI tract
image Submucosal nodules or polypoid masses (< 3 cm) most common, although larger infiltrative masses possible
image Regional enhancing lymphadenopathy common
image Lesions may cause intussusception or obstruction
image Submucosal nodules on barium studies with ulceration may appear as “target” or bull’s-eye lesions
• Lymphadenopathy

image Most commonly involves retroperitoneal lymph nodes
image Commonly hypervascular/avidly enhancing

TOP DIFFERENTIAL DIAGNOSES

• Lymphoma
• Hepatic opportunistic infections
• Intestinal opportunistic infections
• Other causes of hypervascular lymphadenopathy

image Hypervascular lymph node metastases
image Castleman disease
• Other causes of multiple hepatic/splenic nodules 

image Metastatic disease from other malignancies
image Sarcoid
image Hepatic microabscesses or fungal infection

PATHOLOGY

• Associated with human herpesvirus type 8 (HHV8) infection and variable cofactors
• 4 clinical subtypes of KS

image Classic (sporadic) KS: Affects elderly men of Eastern European or Mediterranean origin with visceral involvement uncommon

– Indolent cutaneous involvement of lower extremities
image Endemic (African) KS: Not associated with HIV, and accounts for up to 1/2 of all cancers in parts of Africa
image Iatrogenic (organ transplant-related) KS: Typically develops 1-2 years after transplant, with visceral involvement more likely with heart and liver transplants
image Epidemic (AIDS-related) KS: ↓ prevalence with antiretroviral therapies
image
(Left) Axial CECT in a patient with AIDS and disseminated Kaposi sarcoma (KS) shows widespread thoracic lymphadenopathy. Many of the lymph nodes demonstrate hypervascularity image, characteristic of KS.

image
(Right) Axial CECT in the same patient shows widespread abdominal lymphadenopathy image with hyperenhancing lymph nodes that help to distinguish KS from lymphoma or other causes of lymphadenopathy.
image
(Left) Axial CECT through the pelvis in an AIDS patient shows widespread avidly enhancing adenopathy image. On excisional biopsy, there was histologic evidence of Castleman disease and KS, both of which can present with avidly enhancing lymph nodes.

image
(Right) Axial CECT in a patient with HIV and KS shows widespread lymphadenopathy, including nodes in the groin image that show hyperenhancement. This patient complained of marked edema of the lower extremities, a common symptom of KS-induced inguinal lymphadenopathy.

TERMINOLOGY

Abbreviations

• Kaposi sarcoma (KS)

Definitions

• Low-grade malignancy arising from mesenchymal lining of blood and lymphatic vessels that primarily affects skin and mucous membranes

IMAGING

General Features

• Best diagnostic clue

image Disseminated hypervascular lymphadenopathy with multifocal hepatic or intestinal nodules in patient with known cutaneous KS

Radiographic Findings

• Barium studies of upper or lower gastrointestinal (GI) tract

image May show thickened folds or submucosal nodules
image Nodules in bowel may ulcerate, appearing as “target” or bull’s-eye lesions

CT Findings

• Liver and spleen: Multifocal nodules or masses (few mm to cm)

image Typically hypodense on CECT, but may show delayed enhancement and be invisible on delayed imaging
• GI tract: 50% of patients with cutaneous KS will have GI tract involvement

image Upper GI tract (especially stomach and duodenum) most common, but can affect any part of GI tract
image Submucosal nodules or polypoid masses (< 3 cm) most common, although larger infiltrative masses possible

– Regional enhancing lymphadenopathy common
image May ulcerate, intussuscept, or obstruct
• Lymphadenopathy: Can involve any or all abdominal and pelvic nodal groups

image Most commonly involves retroperitoneal lymph nodes
image Commonly hypervascular/avidly enhancing

Ultrasonographic Findings

• Hepatomegaly with multiple hyperechoic nodules (< 1 cm)

DIFFERENTIAL DIAGNOSIS

Lymphoma

• Can be indistinguishable from KS, although hyperenhancement of nodes or visceral lesions favors KS

Hepatic Opportunistic Infections

• Fungal infection or microabscesses can mimic KS hepatic nodules

Intestinal Opportunistic Infections

• May cause thickened folds in stomach and bowel
• Discrete large masses or hyperenhancing nodes uncommon with infection

Other Causes of Hypervascular Lymphadenopathy

• Hypervascular lymph node metastases
• Castleman disease

Other Causes of Multiple Nodules in Liver

• Metastatic disease from other malignancies
• Sarcoidosis
• Hepatic microabscesses or fungal infection

PATHOLOGY

General Features

• Etiology

image Associated with human herpesvirus type 8 (HHV8) infection and variable cofactors
image 4 clinical subtypes of KS

– Classic (sporadic) KS

image Elderly men of Eastern European or Mediterranean origin
image Usually indolent cutaneous involvement of lower extremities
image Visceral involvement rare (∼ 10%)
– Endemic (African) KS

image Not associated with HIV as risk factor
image Accounts for up to 50% of all cancers in certain parts of Africa
image Localized, indolent, cutaneous disease in > 50%
image Lymphadenopathy ± visceral involvement can be aggressive
– Iatrogenic (organ transplant-related) KS

image Affects about 5% of transplant recipients
image Mucocutaneous disease in 90%; 40% develop visceral, disseminated disease
image Typically develops 1-2 years after organ transplantation
image Patients with KS after liver and heart transplants more likely to develop visceral disease (∼ 50%) than kidney transplants (∼ 25%)
– Epidemic (AIDS-related) KS

image Prevalence among patients with AIDS is decreasing with use of effective antiretroviral therapies
image Most prevalent among homosexual men
image In patients with cutaneous KS, autopsy often identifies visceral involvement in lymph nodes (> 70%), lung (50%), GI (50%), and liver/spleen (30%)

Gross Pathologic & Surgical Features

• Purple-brown spongiform nodules in skin, submucosa, nodes, and viscera

CLINICAL ISSUES

Presentation

• Most common signs/symptoms

image Purple-brown mucocutaneous spongiform lesions
image Similar lesions in viscera on endoscopy or gross inspection
• Other signs/symptoms

image Visceral KS rarely causes significant organ dysfunction

– Patients usually succumb to opportunistic infection or lymphoma

Natural History & Prognosis

• Classic form has good prognosis with resection of tumor
• AIDS-related cases usually die from opportunistic infections

Treatment

• Radiation and chemotherapy plus antiretroviral therapy (epidemic type) for symptomatic or disfiguring lesions
image
Axial CECT in a 36-year-old man with AIDS and cutaneous Kaposi sarcoma shows hyperenhancing lymph nodes in the thorax image, typical of nodal involvement by KS.

image
Axial CECT in the same patient shows abdominal nodal involvement by KS image along with liver metastases image.
image
Axial CECT in the same patient shows additional lymphadenopathy image from KS.
image
Axial CECT in a 35-year-old man with AIDS and disseminated KS shows widespread lymphadenopathy, including nodes with hyperdense enhancement image.
image
Axial CECT demonstrates enhancing lymph node masses image in both groins encasing the groin vessels. This was found to represent KS on excisional biopsy.

SELECTED REFERENCES

1. Restrepo, CS, et al. Kaposi’s sarcoma: imaging overview. Semin Ultrasound CT MR. 2011; 32(5):456–469.

Lee, NK, et al. Hypervascular subepithelial gastrointestinal masses: CT-pathologic correlation. Radiographics. 2010; 30(7):1915–1934.

Restrepo, CS, et al. Imaging manifestations of Kaposi sarcoma. Radiographics. 2006; 26(4):1169–1185.

Antman, K, et al. Kaposi’s sarcoma. N Engl J Med. 2000; 342(14):1027–1038.